Table 2.
Patients’ treatment before and after U-MSCT
| Patient | Treatment before U-MSCT | Treatment 6-mo after U-MSCT |
|---|---|---|
| 1 | Pred 15 mg/d, CYC 0.8 gm/mo, LEF 20 mg/d, HCQ 0.4 gm/d (×26 mo) | Pred 5 mg/d, HCQ 0.4 gm/d |
| 2 | Pred 30 mg/d, CYC 0.8 gm/mo (×16 mo), MMF 1 gm/d (×14 mo) | Pred 5 mg/d, MMF 1 gm/d, HCQ 0.2 gm/d |
| 3 | Pred 20 mg/d, LEF 20 mg/d, Tacrolimus 3 mg/d, HCQ 0.2 gm/d (×34 mo) | Pred 5 mg/d, Tacrolimus 1.5 mg/d, HCQ 0.2 gm/d |
| 4 | Pred 20 mg/d, CYC 0.8 gm/mo, LEF 20 mg/d, HCQ 0.2 gm/d (×8 mo) | Pred 5 mg/d, MMF 1 gm/d, HCQ 0.2 gm/d |
| 5 | Pred 35 mg/d, MMF 1.5 gm/d, HCQ 0.4 gm/d (×16 mo) | Pred 15 mg/d, HCQ 0.2 gm/d |
| 6 | Pred 10 mg/d, CYC 0.8 gm/mo, HCQ 0.2 gm/d (×12 mo) | Pred 5 mg/d |
| 7 | Pred 15 mg/d, CYC 0.8 gm/mo, MMF 1 gm/d (×8 mo) | Pred 5 mg/d, Cyclosporine 150 mg/d, HCQ 0.2 gm/d |
| 8 | Pred 40 mg/d (×1 mo), then tapered to Pred 30 mg/d, CYC 0.8 gm/mo, LEF 20 mg/d, HCQ 0.2 gm/d (×6 mo) | Pred 10 mg/d, Tacrolimus 2 mg/d, HCQ 0.2 gm/d |
| 9 | Pred 20 mg/d, MMF 1.5 gm/d, HCQ 0.4 gm/d (×17 mo) | Pred 5 mg/d, HCQ 0.2 gm/d |
| 10 | Pred 30 mg/d, CYC 1 gm/mo (×12mo), LEF 20 mg/d (×6 mo) | Pred 10 mg/d, CYC 0.6 gm/2 mo, HCQ 0.2 gm/d |
| 11 | Pred 30 mg/d, Tacrolimus 3 mg/d, HCQ 0.2 gm/d (×12 mo) | Pred 5 mg/d, HCQ 0.4 gm/d |
CYC cyclophosphamide, d day, HCQ hydroxychloroquine, LEF leflunomide, MMF mycophenolate mofetil, mo month, Pred prednisone, U-MSCT UC-MSCs transplantation